EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
CPHI Americas 2026: Where Strategic Partnerships, AI, and Advanced Manufacturing Are Shaping Pharma’s Future
CPHI Americas marks a fundamental shift in what a pharmaceutical industry event can be Weve moved toward a contentfirst experience that prioritises s...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
B2B Pharma Content Strategy for HCP Engagement and Multi-Channel Marketing
The pharmaceutical industry has entered a new era of healthcare professional HCP engagement Traditional sales representative visits and print materials are no longer sufficient to influence prescribing decisions or build lasting relationships with physicians pharmacists specialists
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro
Iscalimab is a nondepleting antiCD monoclonal antibody expected to suppress immune responses by blocking the costimulation by antigenpresenting cells through CDCDL ligation
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
ABM Pharma Tactics US: Unlocking B2B Lead Gen Success
Kate Williamson
The Account-based marketing (ABM) pharma strategies are reshaping the US B2B pharma marketing by focusing the high value accounts rather than the lead volume. Pharmaceutical account-based marketing en...
-
2
Flow Cytometry in Immunology: Unveiling Immune Cell Secrets
Kate Williamson
Flow cytometry is a pivotal tool in immunology, enabling the precise analysis of immune cell behavior. Utilizing fluorochrome-labeled antibodies facilitates the identification and characterization of...
-
3
How American Pharma Companies are Addressing Global Health Challenges?
Kate Williamson
America boasts of several pharmaceutical industries that are very vital in meeting the world’s health needs, research, collaborations, and other advanced technologies in the health sector. Provi...
-
4
Evolving Trends and Strategies in Pharmaceutical Marketing: Focus on the American Market
Kate Williamson
This exploration delves into evolving trends and strategies in pharmaceutical marketing, with a focus on the dynamic American market. From digital transformation and patient-centric approaches to data...
-
5
Navigating the Landscape of Pharmacogenomics in Diagnosis to Drug Delivery in Cancer Therapeutics
Vikas Jhawat
Monika Gulia
In the realm of cancer therapeutics, pharmacogenomics has emerged as a critical linchpin in shaping treatment decisions. The relentless adaptability of cancer cells, often culminating in resistance to...
press releasesRead more...
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Eli Lilly and Company NYSE LLY today announced the successful completion of its acquisition of Centessa Pharmaceuticals plc Centessa is a clinicalstage company developing orexin receptor agonists
Verista Highlights COUNTQ® Tray Inspection Systems
Verista a leading provider of automation compliance and quality solutions for the pharmaceutical industry highlights the COUNTQ Tray Inspection System an advanced AIenabled inspection and reconciliation
Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines the Department of Health Abu Dhabi DoH has announced a collaboration with global pharmaceutical
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
Sangamo Therapeutics Inc OTCQB Venture Market SGMO a genomic medicine company today announced that it has entered into two separate asset sale agreements one with Eli Lilly and Company Lilly for Sangamos
Events Read more...
24 - 25
Jun 20266th Edition Drug Safety Symposium 2026
Courtyard by Marriott, Mumbai,...
25 - 26
Jun 2026Pharmacology and Toxicology 2026
Paris, France
07 - 09
Jul 2026The Pharma India Expo 2026
Bombay Exhibition Centre, Mumb...
07 - 09
Jul 2026Nanosciences and Nanotechnologies 2026
Thessaloniki, Greece
08 - 10
Jul 2026CPHI SEA 2026
QSNCC, Bangkok, Thailand
09 - 11
Jul 2026Pharma Pro&Pack Expo 2026
HITEX Exhibition Centre, Hyder...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
LATEST NEWSRead more...
Ionis Gains FDA Approval for TRYNGOLZA to Treat Severe Hypertriglyceridaemia
Ionis Pharmaceuticals has received approval from the US Food and Drug Administration FDA for TRYNGOLZA olezarsen as an addon treatment to diet for adults with severe hypertriglyceridaemia sHTG a condition
Gilead Receives FDA Approval for Trodelvy as First-Line Treatment for Metastatic Triple-Negative Breast Cancer
Gilead Sciences has received approval from the US Food and Drug Administration FDA for Trodelvy sacituzumab govitecanhziy as a firstline treatment for adults with unresectable locally advanced or metastatic
HighRes and Waters Partner to Advance Drug Discovery with Robotic Automation
HighRes has announced a strategic collaboration with Waters Biosciences formerly BD Biosciences to introduce robotic automation capabilities to flow cytometry workflows helping to streamline research activities from basic science to drug discovery
Haisco Grants Nuvectis Global Rights to Two Drug Candidates
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with Nuvectis a US biotechnology company covering two of its internally developed drug candidates for oncology and complementmediated diseases
SystImmune Secures First Approval for Iza-bren to Treat Recurrent or Metastatic Nasopharyngeal Carcinoma in China
SystImmune Inc has announced that its parent company Sichuan Biokin Pharmaceutical Co Ltd has received approval from Chinas National Medical Products Administration NMPA for izabren BLBD
Chai Discovery Partners with Lilly TuneLab to Expand AI Drug Discovery Access for Biotechs
Chai Discovery has partnered with Lilly TuneLab to provide selected biotechnology companies with access to advanced artificial intelligence AI capabilities for earlystage drug discovery
